Treatment for Coronavirus

COVID-19 does not have a specific treatment. Mild cases require treatment to alleviate symptoms, such as rest, water, and fever management. If you have a sore throat, body aches, or a fever, take over-the-counter treatment. 
Antibiotics are ineffective because they treat bacteria rather than viruses. Antibiotics are given to persons who have COVID-19 for an infection that comes with the disease.

Patients with severe symptoms should be admitted to the hospital. Remdesivir (Veklury), an antiviral drug, was the first to be approved by the FDA for the treatment of COVID-19 patients hospitalised. Evidence reveals that those who were treated with remdesivir recovered in roughly 11 days, compared to 15 days for those who were given a placebo.

Many clinical trials are currently underway to investigate and develop new COVID-19 therapies that have been utilised to treat other diseases. Tocilizumab, a drug used to treat autoimmune diseases, is now undergoing clinical testing. The FDA is also permitting clinical research and hospital use of blood plasma from persons who have recovered from COVID-19 to aid in the development of immunity in others. This is referred to as convalescent plasma. There is currently insufficient evidence of its effectiveness.

The anti-malarial medications hydroxychloroquine and chloroquine were evaluated as possible treatments early in the pandemic. After tests revealed that the medications were ineffective and the hazards outweighed the benefits, the FDA revoked the emergency use order.
Dexamethasone, a steroid medicine used to treat arthritis, blood/hormone/immune system abnormalities, and allergic responses, is one of the steroid treatments utilised. More efficacy research is still being carried out.
 

Tags
Clinical Trials Auditing Conferences Medical Research Conferences Regulatory Affairs Conferences Clinical Trials Conferences 2022 Canada Clinical Research Conference 2022 Japan Clinical Research Conferences 2022 Clinical Trials Conferences Clinical Research Conferences Medical Case Reports Conferences Clinical Trials Conferences 2022 Medical Writing Conferences

+1-873-889-8976